August 21, 2017 4:34 AM ET

Biotechnology

Company Overview of OPKO Biologics

Key Executives for OPKO Biologics

NameBoard RelationshipsTitleAge
Abraham Havron Ph.D.67 RelationshipsChief Executive Officer and Director69
Shai Novik M.B.A.15 RelationshipsPresident and Director 51
Steven Schaeffer CPANo RelationshipsChief Financial Officer and Principal Accounting Officer67
Fuad Fares D.Sc. 32 RelationshipsDirector and Chief Scientific Officer of Prolor Biotech Ltd62
Eyal Fima M.B.A., Ph.D.No RelationshipsChief Operating Officer of Prolor Biotech Ltd52

OPKO Biologics Board Members*

NameBoard RelationshipsPrimary CompanyAge
Philip Frost M.D., Ph.D. 154 RelationshipsOpko Health, Inc.78
Abraham Havron Ph.D. 67 RelationshipsOPKO Biologics69
Shai Novik M.B.A. 15 RelationshipsOPKO Biologics51
Fuad Fares D.Sc. 32 RelationshipsOPKO Biologics62
Steven D. Rubin J.D., Esq. 112 RelationshipsOpko Health, Inc.57
View All Board Members

OPKO Biologics Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee J.D., Esq.Steven D. Rubin112 Relationships3 Executives
Compensation Committee M.D., Ph.D.Philip Frost154 Relationships3 Executives
Corporate Governance Committee M.D., Ph.D.Philip Frost154 Relationships3 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$270.0K
270.0K
387.2K
Bonus$60.0K
60.0K
237.8K
Total Short Term Compensation
Not meaningful
Total Value of Options$330.0K
330.0K
18.6M
Compensation as of Fiscal Year 2012
OPKO Biologics CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Cellectar Biosciences, Inc. Announces Management Changes
August 18, 2017 9:00 PM ET
Isofol Medical AB (publ) Appoints Sven Erickson as Chief Commercial Officer
August 18, 2017 6:32 PM ET
Kane Biotech Inc. Announces Resignation of Sarah Prichard as Director
August 18, 2017 11:12 AM ET
RHS Limited Appoints Alwin Hui as Chief Commercial Officer
August 18, 2017 3:43 AM ET
Immunocellular Therapeutics, Ltd. Announces Resignation of Mark A. Schlossberg and Gregg A. Lapointe from the Board of Directors
August 17, 2017 8:32 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact OPKO Biologics, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.